# US 2023/0058048 A1 · Systems and methods for increasing prior authorization success rate for specialty drugs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0058048 A1
- Document ID: US20230058048A1
- Status: Published application
- Kind: A1
- Application number: 17/409,192
- Filed: 2021-08-23
- Published: 2023-02-23
- Earliest claimed: 2021-08-23
- Assignees: Change Healthcare Holdings, LLC
- Applicants: Change Healthcare Holdings, LLC
- Inventors: James Delbert Smith
- Web page: https://patentgrep.com/patent/US20230058048A1

## CPC

- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G06Q 10/10: Office automation; Time management
- G16H 15/00: ICT specially adapted for medical reports, e.g. generation or transmission thereof
- G16H 40/20: for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR

## Abstract

A system for increasing the rate of claim approval for specialty drugs is provided. The system monitors the approval and disapproval rates for claims related to specialty medications for multiple providers (e.g., pharmacies) due to missing or incomplete prior authorization requests. When the approval rate for a particular drug for a provider falls below a threshold value due to incomplete or missing prior authorization requests, the system provides the manufacturer of the drug with training on how to complete prior authorization requests for the drug. For example, the provider may be invited to an online course, or instructors may offer to visit the provider to provide additional training. The drug manufacturers may reimburse the claim processing system for identifying those providers who could benefit from the training.

## Claims

### Claim 1

A method comprising:
receiving a claim from a provider by a computing device, wherein the claim is for a drug produced by a manufacturer;
transmitting the claim to a claim processing system;
receiving a claim denial response from the claim processing system;
updating one or more metrics for the provider and the drug based on the claim denial response by the computing device;
determining whether the one or more metrics fall below a threshold for the manufacturer and the drug by the computing device; and
if it is determined that the one or more metrics fall below the threshold, initiating training for the provider by the computing device.

### Claim 2 (depends on 1)

The method of claim 1, wherein the drug is a specialty drug.

### Claim 3 (depends on 1)

The method of claim 1, further comprising receiving compensation for the training by the manufacturer.

### Claim 4 (depends on 1)

The method of claim 1, wherein at least one metric of the one or more metrics is an approval rate.

### Claim 5 (depends on 1)

The method of claim 1, wherein initiating training comprises providing a link to training materials to the provider.

### Claim 6 (depends on 1)

The method of claim 1, wherein the provider is a pharmacy or a physician.

### Claim 7 (depends on 1)

The method of claim 1, wherein the training is training on completing paperwork related to a prior authorization.

### Claim 8

A method comprising:
monitoring acceptances and denials of claims due to prior authorization requests for a plurality of drugs associated with a manufacturer by a computing device, wherein each claim is associated with a provider of a plurality of providers;
for each provider of the plurality of providers and each drug of the plurality of drugs, computing an acceptance rate for the claims for the drug and the provider by the computing device;
determining that a computed acceptance rate for a first drug of the plurality drugs and a first provider of the plurality of providers falls below a threshold by the computing device; and
in response to the determination, initiating training for the first provider on preparing prior authorization requests for the first drug by the computing device.

### Claim 9 (depends on 8)

The method of claim 8, wherein the drug is a specialty drug.

### Claim 10 (depends on 8)

The method of claim 8, further comprising receiving compensation for the training by the manufacturer.

### Claim 11 (depends on 8)

The method of claim 8, wherein initiating training comprises providing a link to training materials to the first provider.

### Claim 12 (depends on 11)

The method of claim 11, further comprising receiving the training materials from the manufacturer.

### Claim 13 (depends on 8)

The method of claim 8, wherein the first provider is a pharmacy or a physician.

### Claim 14 (depends on 8)

The method of claim 8, wherein the training is training on completing paperwork related to the prior authorization request for the first drug.

### Claim 15 (depends on 8)

The method of claim 8, further comprising:
providing a graphical user interface to the manufacturer; and
displaying some or all of the computed acceptance rates for the plurality of drugs for some or all of the plurality of providers in the graphical user interface.

### Claim 16 (depends on 8)

The method of claim 8, further comprising receiving the threshold from the manufacturer.

### Claim 17

A system comprising:
at least one computing device; and
a memory storing instructions that when executed by the at least one computing device cause the at least one computing device to:
receive a claim from a provider, wherein the claim is for a drug produced by a manufacturer;
transmit the claim to a claim processing system;
receive a claim denial response from the claim processing system;
update one or more metrics for the provider and the drug based on the claim denial response;
determine whether the one or more metrics fall below a threshold for the manufacturer and the drug; and
if it is determined that the one or more metrics fall below the threshold, initiate training for the provider.

### Claim 18 (depends on 17)

The system of claim 17, wherein the drug is a specialty drug.

### Claim 19 (depends on 17)

The system of claim 17, further comprising receiving compensation for the training by the manufacturer.

### Claim 20 (depends on 17)

The system of claim 17, wherein the metric is an approval rate.
